Zhiran Medical Funding: $43M Raised, Series A (2026)
Zhiran Medical is based in Beijing, China. It has raised $43M in total funding. Latest round: Series A.
Zhiran Medical funding overview
Zhiran Medical is based in Beijing, China. Zhiran Medical has raised $43M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2026. The round record for Zhiran Medical runs through 2026; nothing later has been disclosed. Investors on record include Zhongke Chuangxing, Legend Capital, Beijing Medical and Health Industry Investment Fund, IDG Capital, Shunwei Capital, Lenovo Capital & Incubation Group and 11 others. 17 distinct backers are named across the disclosed rounds.
Zhiran Medical at a glance
Total raised
$43M
Latest round
Series A
Latest round date
February 2026
Headquarters
Beijing, China
Notable investors
Zhongke Chuangxing, Legend Capital, Beijing Medical and Health Industry Investment Fund, IDG Capital, Shunwei Capital, Lenovo Capital & Incubation Group, Yuansheng Venture Capital, Sequoia Capital China
Frequently asked about Zhiran Medical funding
How much has Zhiran Medical raised?
Zhiran Medical has raised $43M in total disclosed funding across the rounds on record.
Who has invested in Zhiran Medical?
Zhongke Chuangxing, Legend Capital, Beijing Medical and Health Industry Investment Fund, IDG Capital, Shunwei Capital, Lenovo Capital & Incubation Group are named among the investors backing Zhiran Medical.
What was the latest Zhiran Medical funding round?
The most recent disclosed round is a Series A, announced in February 2026.
Where is Zhiran Medical based?
Zhiran Medical is based in Beijing, China.
When did Zhiran Medical last raise?
The last disclosed Zhiran Medical round closed in February 2026 at Series A.
Every Zhiran Medical figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Beijing at a similar stage.